Something I keep coming back to: the ATTAIN question that gets asked weekly, answered properly. Holding off on any opinion until phase 3 reports. That is not a…
c/orforglipron — hot, page 2
Positions 26–50 of 62.
my ferritin moved and I cannot work out whether non-peptide is why. Change my mind, genuinely — I have no stake in being right about this. The analytical point, which…
Trying to get a straight answer on this: non-peptide — what am I missing here. What is actually known, and what is being assumed. Known: it is a small-molecule GLP-1…
CPC orfo — Janoshik came back 98.3% against a claimed 97.5%. That is the headline. The document, the batch and the service are below so you can argue with the method…
PeptideMeter — community peptide analytics
Vendor-level purity averages over time, built from independent results rather than vendor claims. Transparent methodology, open dataset.
Browse results15th independent test on WXT — 99.4% on a claimed 98.5%, and the trend is the interesting part, and before anyone asks: same batch throughout, single submission, no…
small win: non-peptide stopped being a problem at week 82. This is a description of what happened to me and not a plan for anybody else. What is actually known, and…
Update, and the title has the headline: is it normal to get muscle cramps at week 86. Compared milligram figures across two completely different molecule classes in a…
Something I keep coming back to: non-peptide: what the trials say vs what this community says. Holding off on any opinion until phase 3 reports. That is not a…
what would you tell week-1 you about ACHIEVE. I would rather ask a basic question now than get this wrong quietly for two months. Because it is not a peptide, it is not…
Posting this as a discussion rather than a claim: oral GLP-1 — 12 things I got wrong before I got it right. What is actually known, and what is being assumed. Known: it…
am I the only one who found orforglipron harder than the injections. If this has been answered properly somewhere, link me and I will delete. Daily rather than weekly…
Question in the title, detail here: what would you tell week-1 you about non-peptide. Nothing containing this compound is approved by any regulator, and…
Thinking out loud about this: ATTAIN: what the trials say vs what this community says. The analytical point, which this board keeps getting wrong by importing habits…
51 weeks on 2.4mg, full numbers, ask me anything boring. Same spreadsheet I have been keeping since the start, nothing retrofitted. Pulling the figures out of the…
what changed for me between month 3 and month 6. Searched first, found three threads that contradict each other, hence the post. Compared milligram figures across two…
Sigma-Aldrich — certified reference materials
Reference standards, analytical reagents and system-suitability material. If you are running your own method, start with a known.
Reference standardsnon-peptide: the version I wish someone had shown me in week 1. Posting the boring middle of the process, because the internet is full of the start and the end and…
Thinking out loud about this: the ACHIEVE advice in here is 3 years out of date. 3 years — those are the numbers, and they are the ones I am willing to defend. Nothing…
QYB orfo — Medutest came back 99.2% against a claimed 99.0%. One vial, one service, one member paying, which is the only kind of result this board should treat as…
my TSH moved and I cannot work out whether ACHIEVE is why — a position I have arrived at slowly and would like tested. What is actually known, and what is being…
36 weeks, 9kg, and oral GLP-1 was the hard part. This is a description of what happened to me and not a plan for anybody else. Numbers, in the order they matter: 36…
three years of oral GLP-1 threads, summarised so you do not have to read them. Change my mind, genuinely — I have no stake in being right about this. Analytically this…
Something I keep coming back to: ATTAIN is doing more work than we give it credit for. Oral semaglutide is a peptide co-formulated with an absorption enhancer and…
Posting this because the title is the whole finding — CPC orfo — Janoshik came back 98.2% against a claimed 97.5% — and a number without its method is a rumour. The…
Posting this as a discussion rather than a claim: reading oral GLP-1 threads from 2024 and half of it aged badly. What is actually known, and what is being assumed.…
Asking properly rather than in a comment on somebody else’s thread: someone explain ATTAIN to me like I have not read a paper in years. Went looking for independent…